Learn what Wall Street already knows in our "Billion Dollar Secret" guide.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click
OK. If you do not, click Cancel.
Back to top
Surging Rank, Surging Stock; Why Computer Programs & Systems (CPSI) Is a Winner
February 19, 2014
CPSI BABY OMCL
One company that should be on your radar is
Computer Programs & Systems Inc. ( CPSI - Snapshot Report) . The stock of this medical information provider has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.
A key reason for this move has been the positive trend in the earnings estimate revisions picture. For CPSI’s full year estimate, we have seen 10 estimates go higher in the past 30 days, compared to no downward revisions. This trend has helped the consensus estimate to trend higher, going from $3.00 a share a month ago to its current level at $3.30.
This positive shift in estimates has made some investors take notice and buy the stock. In fact, CPSI has seen some pretty solid trading lately, as the company has moved higher by 12.1% in the past month.
If Computer Programs & Systems can keep up this great momentum on the earnings estimate front and continue to impress analysts, we could see more gains ahead for this company, suggesting that you might want to put CPSI on your watch list for the future.
Other top-ranked stocks worth considering in the medical space include Natus Medical Inc. ( BABY - Snapshot Report) , Auxilium Pharmaceuticals Inc. , and Omnicell, Inc. ( OMCL - Analyst Report) . While Natus Medical and Auxilium Pharmaceuticals hold a Zacks Rank #1 (Strong Buy), Omnicell, Inc. carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>